Form 4: Trupanion CFO Qureshi Reports RSU Grants and Vesting
Insider Transaction Report
Trupanion's Chief Financial Officer, Fawwad Qureshi, reported new restricted stock unit grants and the vesting of previous awards.
Summary
- Fawwad Qureshi, Chief Financial Officer of Trupanion, Inc. (TRUP), was granted 35,482 restricted stock units (RSUs) on February 20, 2026.
- Several tranches of previously granted RSUs vested on February 22, 2026, resulting in the acquisition of 913, 5,248, and 313 shares of common stock.
- A total of 1,829 shares of common stock were withheld by the issuer to satisfy income tax withholding obligations related to the vesting of these RSUs.
- The shares withheld for tax purposes were valued at $27.16 per share.
- The transactions were made pursuant to a Rule 10b5-1 plan.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a routine and generally positive disclosure, reflecting ongoing executive compensation and alignment of interests, with no unexpected negative events or significant deviations from standard practice.
Positives
- The Chief Financial Officer received a new grant of 35,482 restricted stock units, increasing his potential future equity stake in the company.
- Multiple tranches of previously granted restricted stock units vested, converting into common stock and increasing the CFO's direct beneficial ownership of the company's equity.
- The vesting and new grant demonstrate ongoing executive compensation and alignment of management's interests with shareholders.
Negatives
- A total of 1,829 shares of common stock were withheld by the issuer to cover income tax obligations, reducing the net number of shares received by the reporting person from the vesting events.
Future Outlook
The Chief Financial Officer has future vesting events for the newly granted 35,482 RSUs, with 1/8th vesting on May 22, 2026, and subsequent 1/8th portions vesting quarterly thereafter, subject to continued service. Other previously granted RSUs also have ongoing quarterly vesting schedules through 2028.
Management Comments
- The reported transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Industry Context
StockSavvy.ai notes that RSU grants and their subsequent vesting are standard components of executive compensation packages across various industries, including the pet insurance sector. This practice aims to align management's long-term interests with those of shareholders by tying a significant portion of compensation to the company's stock performance and executive retention.
Comparison to Industry Standards
- StockSavvy.ai observes that the structure of RSU grants with multi-year, quarterly vesting schedules is a common practice for executive compensation in publicly traded companies, including those in the specialized insurance and pet care sectors.
- This compensation mechanism is widely used to incentivize long-term performance and executive retention, consistent with global benchmarks for corporate governance and executive reward programs.
- While specific comparable companies or projects are not detailed in this Form 4, the general approach to equity compensation for a Chief Financial Officer at a company like Trupanion aligns with practices seen at similar-sized firms in competitive markets.
Stakeholder Impact
- Shareholders: The increased equity ownership by the CFO through RSU grants and vesting aligns management's financial interests with shareholder value creation.
- Employees (CFO): The CFO benefits from ongoing equity compensation, providing a significant incentive for long-term performance and retention.
Next Steps
- Future vesting of the 35,482 RSUs will occur quarterly, with the first 1/8th vesting on May 22, 2026, subject to continued service.
- Ongoing quarterly vesting of other previously granted RSUs will continue through their respective schedules until their expiration dates in 2027 and 2028.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Reporting person was granted 7,304 restricted stock units (RSUs), vesting 1/8th on May 22, 2024, then quarterly. |
| 02/27/2024 | Reporting person was granted 5,000 restricted stock units (RSUs), vesting 1/4th on February 25, 2025, then 1/16th quarterly. |
| 02/27/2025 | Reporting person was granted 41,980 restricted stock units (RSUs), vesting 1/8th on May 22, 2025, then quarterly. |
| 02/25/2025 | First vesting date for the 5,000 RSU grant from February 27, 2024. |
| 02/20/2026 | Reporting person was granted 35,482 restricted stock units (RSUs). |
| 02/22/2026 | Multiple RSU conversions to common stock and shares withheld for tax obligations occurred. |
| 02/24/2026 | Date the Form 4 was signed and filed. |
| 05/22/2026 | First vesting date for the 35,482 RSU grant from February 20, 2026. |
| 02/22/2027 | Expiration date for the 41,980 RSU grant from February 27, 2025. |
| 02/22/2028 | Expiration date for the 35,482 RSU grant from February 20, 2026. |
| 02/25/2028 | Expiration date for the 5,000 RSU grant from February 27, 2024. |
Keywords
Trupanion, TRUP, Fawwad Qureshi, Chief Financial Officer, CFO, Restricted Stock Units, RSU, Insider Transaction, Form 4, Executive Compensation, Stock Vesting, Equity Grant, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.